NCT00359918

Brief Summary

Prehospital initiated facilitation of primary percutaneous coronary intervention by fibrinolysis might be helpful in re-opening the infarct related artery prior to percutaneous coronary intervention. This studies tests the hypothesis that prehospital initiated facilitated PCI is superior to primary percutaneous coronary intervention with respect to infarct size.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
162

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Aug 2006

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2006

Completed
Same day until next milestone

Study Start

First participant enrolled

August 1, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 3, 2006

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2009

Completed
Last Updated

June 26, 2018

Status Verified

June 1, 2018

Enrollment Period

3 years

First QC Date

August 1, 2006

Last Update Submit

June 21, 2018

Conditions

Keywords

infarctionfacilitated PCIprimary PCIinfarct sizefibrinolysisST-elevation myocardial infarction (STEMI)

Outcome Measures

Primary Outcomes (1)

  • Infarct size and microvascular obstruction assessed by MRI

    1-6 days

Secondary Outcomes (2)

  • Clinical endpoints (bleeding, death, Re-MI, stroke)

    30 days

  • ST-segment resolution

    90 min

Study Arms (2)

Prehospital facilitated PCI

EXPERIMENTAL
Drug: fibrinolysis

Primary PCI

ACTIVE COMPARATOR
Procedure: Primary PCI

Interventions

Primary PCI

Also known as: Primary PCI
Prehospital facilitated PCI
Primary PCIPROCEDURE

Primary PCI

Primary PCI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Angina pectoris \< 3 hours
  • ST-elevation myocardial infarction

You may not qualify if:

  • Active bleeding
  • Active gastric ulcus
  • Previous stroke
  • Uncontrolled hypertension (\> 200 mmHg)
  • Cerebral surgery \< 8 weeks
  • Major surgery \< 4 weeks
  • Malignancy
  • Treatment with coumarines
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Leipzig - Heart Center

Leipzig, 04289, Germany

Location

Related Publications (2)

  • de Waha S, Eitel I, Desch S, Fuernau G, Lurz P, Stiermaier T, Blazek S, Schuler G, Thiele H. Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine. Trials. 2014 Jun 25;15:249. doi: 10.1186/1745-6215-15-249.

  • Thiele H, Eitel I, Meinberg C, Desch S, Leuschner A, Pfeiffer D, Hartmann A, Lotze U, Strauss W, Schuler G; LIPSIA-STEMI Trial Group. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction). JACC Cardiovasc Interv. 2011 Jun;4(6):605-14. doi: 10.1016/j.jcin.2011.01.013.

MeSH Terms

Conditions

Myocardial InfarctionInfarctionST Elevation Myocardial Infarction

Interventions

Fibrinolysis

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Intervention Hierarchy (Ancestors)

Blood CoagulationHemostasisBlood Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Holger Thiele, MD, PhD

    Heart Center Leipzig - University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PI

Study Record Dates

First Submitted

August 1, 2006

First Posted

August 3, 2006

Study Start

August 1, 2006

Primary Completion

August 1, 2009

Study Completion

August 1, 2009

Last Updated

June 26, 2018

Record last verified: 2018-06

Locations